NYSE$IQV

IQVIA Holdings Inc. · Q3 2020 earnings

Q3 2020 earnings · · Investor relations

Briefing

IQVIA's third-quarter results were reported, with revenue and Adjusted EBITDA reaching $2,786 million and $604 million, respectively.

IQVIA reported third-quarter results with revenue of $2,786 million and Adjusted EBITDA of $604 million. The company raised full-year 2020 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS and provided a full-year 2021 outlook for revenue $12,300 million to $12,600 million, Adjusted EBITDA $2,725 million to $2,800 million and Adjusted Diluted EPS $7.65 to $7.95.

  • Third quarter revenue of $2,786 million and Adjusted EBITDA of $604 million
  • GAAP Diluted Earnings per Share of $0.52 and Adjusted Diluted Earnings per Share of $1.63
  • Technology & Analytics Solutions revenue grew 10.2 percent reported and 9.2 percent on a constant currency basis
  • R&D Solutions quarterly net book-to-bill ratio was 1.71x; next twelve months revenue from backlog increased over $400 million to $5.8 billion

Headline financials

Total Revenue

$2.79B

Previous: $2.77B+0.6%
EPS (adj)

$1.63

Previous: $1.60+1.9%
R&D Solutions contracted backlog

$21.7B

Previous: $18.3B+18.5%
Free Cash Flow

$101M

Previous: $57M+77.2%
Net Income

$101M

Previous: $57M+77.2%
Operating Income

$187M

Previous: $204M-8.3%
Gross Profit

$600M

Previous: -$1.85B+132.4%
Cash & Equivalents

$1.46B

Previous: $863M+69.6%
Total Assets

$23.8B

Previous: $22.9B+4.1%
Stock-Based Comp

$33M

Previous: $27M+22.2%

Revenue & EPS history

IQVIA · Revenue · Quarterly

$2.79B

Q3 2020+0.6%vs Q3 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

IQVIA · $2.79B total across 3 segments · Q3 2020

  • Research & Development Solutions
    $1.4B-4.5%
  • Technology & Analytics Solutions
    $1.21B+10.2%
  • Contract Sales & Medical Solutions
    $179M-13.9%

Forward guidance

For the full year of 2021, the company expects revenue of between $12,300 million and $12,600 million, Adjusted EBITDA of between $2,725 million and $2,800 million, and Adjusted Diluted Earnings per Share of between $7.65 and $7.95.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2020

Historical avgQ3 2020

+1.4%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+1.9%

Avg return

30 days after

65%

37 / 57 earnings

Positive

+12.5%

Q2 2018

Best reaction

-10.7%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+7.7%+10.9%+13.9%
Q4 2025-10.7%-9.9%-13.8%
Q3 2025+0.3%-0.4%+6.6%
Q2 2025-0.4%+1.1%-1.6%
Q1 2025-4.0%-2.2%-3.2%
Q4 2024+2.2%-2.2%-6.7%
Q3 2024-3.2%-1.5%-7.0%
Q2 2024+6.3%+6.7%+10.0%
Q1 2024-4.1%-1.6%-5.9%
Q4 2023+12.2%+10.8%+17.4%
Q3 2023+5.3%+9.7%+20.0%
Q2 2023-2.1%-3.1%-0.5%
Q1 2023-0.9%-2.3%+5.0%
Q4 2022+0.8%-1.4%-14.4%
Q3 2022+1.4%+6.1%+11.3%
Q2 2022+0.5%-0.4%+8.3%
Q1 2022+6.1%+5.0%+6.7%
Q4 2021-3.2%-4.8%-6.9%
Q3 2021+2.1%+1.8%+6.6%
Q2 2021-0.8%+0.2%+4.5%
Q1 2021+6.1%+7.0%+9.1%
Q4 2020+4.9%+4.8%+1.6%
Q3 2020+3.2%+2.1%+3.4%
Q2 2020+2.9%+3.4%+0.4%
Q1 2020+8.5%+3.5%+10.9%
Q4 2019+2.5%+1.6%-26.6%
Q3 2019-3.8%-2.4%-2.7%
Q2 2019+2.1%+1.6%-2.3%
Q1 2019-2.0%-0.1%-2.2%
Q4 2018+7.6%+7.3%+7.4%
Q3 2018-3.5%-5.3%-8.4%
Q2 2018+12.5%+8.2%+11.7%
Q1 2018-0.7%+0.2%+2.6%
Q4 2017+1.5%+1.7%+5.6%
Q3 2017+6.1%+6.5%+2.7%
Q2 2017-1.3%-1.0%+4.4%
Q1 2017-3.7%-2.0%+3.0%
Q4 2016-2.7%-4.1%+0.5%
Q3 2016+0.8%+4.1%+3.3%
Q2 2016+3.3%+4.2%+0.3%
Q1 2016-5.9%
Q4 2015+3.6%
Q3 2015-6.2%
Q2 2015+2.6%
Q1 2015-4.9%
Q4 2014+4.3%
Q3 2014+0.9%
Q2 2014-3.1%
Q1 2014+0.4%
Q4 2011+7.5%
Q4 2013+7.5%
Q3 2012+0.1%
Q3 2013+0.1%
Q2 2012+0.8%
Q2 2013+0.8%
Q1 2012+5.0%
Q4 2012+5.0%
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro